Steven Cohen’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,200
Closed -$597K – 4067
2026
Q2
$597K Buy
23,200
+600
+3% +$12.3K ﹤0.01% 3101
2026
Q1
$434K Buy
+22,600
New +$450K ﹤0.01% 3181

Other funds holding DNLI

Steven Cohen's DNLI Position: Q3 2026 in Review

Steven Cohen opened a new position in Denali Therapeutics (DNLI) in Q3 2026: 61,189 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #2677 among its holdings. This is a return to the name: Steven Cohen previously reported a position in DNLI as recently as Q4 2025.

Steven Cohen first reported a position in DNLI in Q3 2022 and has held it in 11 quarters since. The position peaked at $36.6M in Q3 2025. 287 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.

  • Steven Cohen held 61,189 shares of Denali Therapeutics worth $1.26M as of Q3 2026.
  • Denali Therapeutics was a new Steven Cohen position in Q3 2026.
  • Denali Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2677 holding.
  • Steven Cohen first reported a position in Denali Therapeutics in Q3 2022 and has held it in 11 quarters since.
  • Steven Cohen's Denali Therapeutics position peaked at $36.6M in Q3 2025.
  • 287 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.